A Randomized Controlled Study Was Done to Evaluate the Efficacy

A randomized controlled study was done to evaluate the efficacy of a novel medication in reducing severe cutaneous responses in individuals with rheumatoid arthritis treated with adalimumab. 75 persons with rheumatoid arthritis were given the new medicine in addition to adalimumab, whereas the other 75 got a placebo in addition to adalimumab. According to the findings, six individuals in the new treatment group experienced severe cutaneous responses, compared to nine in the placebo group. Which of the following best describes the new medication group's relative risk decrease for severe cutaneous reactions?

A) 0) 08
B) 0) 10
C) 0) 12
D) 0) 33
E) 0) 67

Correct Answer:

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Access For Free